Recent News
On January 12, 2026 Haemonetics announced the acquisition of Vivasure Medical for an upfront €100 million plus contingent consideration up to €85 million. In March 2026 the company published its 2024–2025 Corporate Responsibility Report, and in late March 2026 Haemonetics filed its annual report noting completion of the divestiture of the Whole Blood product line during fiscal 2025.
Technical Analysis
Directional indicators show an emerging trend: ADX at 21.26 points to an evolving directional move rather than a mature trend. DI+ sits at 19.68 and shows an increasing trend, while DI− at 26.04 has peak-and-reversed; together the indicator trends imply a shift toward bullish directional pressure even though DI− currently reads higher than DI+.
MACD reads −1.29 with the MACD line rising above the signal line (signal −1.73), a bullish momentum signal given the crossover and the MACD trend increasing from lower levels.
MRO registers 20.31 and is positive, indicating the current price sits above WMDST’s target and therefore carries potential downward pressure if momentum stalls; the magnitude suggests a measurable but not extreme mean-reversion pressure.
RSI at 41.59 and rising signals improving buying interest from below neutral territory rather than overbought conditions, supporting the case for further upside if momentum holds.
Price structure shows the close at $59.53 trading above the 20-day average ($57.14) and near the 12‑day EMA pivot that recorded a dip-and-reversal; however the stock remains below the 200‑day average ($64.83) and below the ichimoku cloud boundary (Senkou A $63.09, Senkou B $71.64), which keeps broader trend resilience in question. Short-term support aligns with the super trend lower at $55.71 and 1x Bollinger band lower at $55.17; resistance clusters near the 50‑day average $60.77 and the $65 zone where the price target mean sits.
Fundamental Analysis
Revenue totaled $338,967,000 with YoY revenue growth of 3.06% and QoQ growth of 93.27%. Gross margin stands at 59.71%, up 7.52 percentage points YoY. Operating margin registers 20.09% and EBIT margin 19.88%; both margins sit slightly below the industry peer mean and median (industry peer mean EBIT margin ~20.75%, median ~20.88%) but remain well inside the industry peer range.
EBIT at $67,396,000 and EBITDA at $94,781,000 reflect positive operating leverage; EBIT margin improved YoY by 17.40% and QoQ by 11.27%, supporting the valuation case for improving profitability. Net income of $44,740,000 and EPS actual $0.95 exceeded the estimate $0.90, producing an EPS surprise of 5.56%.
Balance sheet and cash flow metrics show $363,367,000 in cash and short-term investments and net debt of $861,366,000. Debt-to-assets sits at 49.17%, above the industry peer mean of ~28.07%, while debt-to-equity of 1.3437 exceeds the industry peer mean of ~0.5361, indicating higher leverage relative to peers. Interest coverage remains positive at 9.08x but below the industry peer mean (≈20.97x).
Free cash flow totaled $87,215,000 with a free cash flow yield of 2.59%, which registers above the industry peer mean free cash flow yield (~0.89%). Operating cash flow at $93,564,000 and a cash conversion ratio of 0.839 support cash generation, and free cash flow converts to net income at roughly 195% (free cash to net income 1.949).
Efficiency metrics show asset turnover of 0.137 and days inventory outstanding ~226 days; asset turnover sits slightly above the industry peer mean of ~0.1266. Return on equity at 4.91% and return on assets at 1.81% both improved YoY, with return on equity up 18.75% YoY.
Valuation context: WMDST values the stock as under-valued. Market capitalization approximates $3.37 billion with enterprise multiple near 44.68 and an EVR of 12.49. Price targets from consensus show a mean near $65.23 while the current close sits at $59.53, suggesting modest upside relative to the mean target.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-05 |
| NEXT REPORT DATE: | 2026-05-07 |
| CASH FLOW | Begin Period Cash Flow | $ 296.4 M |
| Operating Cash Flow | $ 93.6 M | |
| Capital Expenditures | $ -6.35 M | |
| Change In Working Capital | $ 11.8 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 66.9 M | |
| End Period Cash Flow | $ 363.4 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 339.0 M | |
| Forward Revenue | $ 117.7 M | |
| COSTS | ||
| Cost Of Revenue | $ 136.6 M | |
| Depreciation | $ 16.5 M | |
| Depreciation and Amortization | $ 27.4 M | |
| Research and Development | $ 14.2 M | |
| Total Operating Expenses | $ 270.9 M | |
| PROFITABILITY | ||
| Gross Profit | $ 202.4 M | |
| EBITDA | $ 94.8 M | |
| EBIT | $ 67.4 M | |
| Operating Income | $ 68.1 M | |
| Interest Income | — | |
| Interest Expense | $ 7.4 M | |
| Net Interest Income | $ -7.42 M | |
| Income Before Tax | $ 60.0 M | |
| Tax Provision | $ 15.2 M | |
| Tax Rate | 25.4 % | |
| Net Income | $ 44.7 M | |
| Net Income From Continuing Operations | $ 44.7 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.90 | |
| EPS Actual | $ 0.95 | |
| EPS Difference | $ 0.05 | |
| EPS Surprise | 5.556 % | |
| Forward EPS | $ 1.33 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 2.5 B | |
| Intangible Assets | $ 1.0 B | |
| Net Tangible Assets | $ -115.11 M | |
| Total Current Assets | $ 943.7 M | |
| Cash and Short-Term Investments | $ 363.4 M | |
| Cash | $ 363.4 M | |
| Net Receivables | $ 195.7 M | |
| Inventory | $ 321.2 M | |
| Long-Term Investments | $ 216.1 M | |
| LIABILITIES | ||
| Accounts Payable | $ 48.7 M | |
| Short-Term Debt | $ 304.7 M | |
| Total Current Liabilities | $ 539.9 M | |
| Net Debt | $ 861.4 M | |
| Total Debt | $ 1.2 B | |
| Total Liabilities | $ 1.6 B | |
| EQUITY | ||
| Total Equity | $ 911.5 M | |
| Retained Earnings | $ 381.1 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 19.46 | |
| Shares Outstanding | 46.829 M | |
| Revenue Per-Share | $ 7.24 | |
| VALUATION | Market Capitalization | $ 3.4 B |
| Enterprise Value | $ 4.2 B | |
| Enterprise Multiple | 44.677 | |
| Enterprise Multiple QoQ | 12.694 % | |
| Enterprise Multiple YoY | 11.191 % | |
| Enterprise Multiple IPRWA | high: 158.913 median: 85.622 mean: 83.183 HAE: 44.677 low: -144.328 |
|
| EV/R | 12.492 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.733 | |
| Asset To Liability | 1.577 | |
| Debt To Capital | 0.573 | |
| Debt To Assets | 0.492 | |
| Debt To Assets QoQ | -1.956 % | |
| Debt To Assets YoY | 24484.0 % | |
| Debt To Assets IPRWA | high: 0.828 HAE: 0.492 mean: 0.281 median: 0.262 low: 0.002 |
|
| Debt To Equity | 1.344 | |
| Debt To Equity QoQ | -6.832 % | |
| Debt To Equity YoY | 23895.0 % | |
| Debt To Equity IPRWA | high: 2.909 HAE: 1.344 mean: 0.536 median: 0.472 low: -1.334 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 3.701 | |
| Price To Book QoQ | 25.171 % | |
| Price To Book YoY | -12.913 % | |
| Price To Book IPRWA | high: 15.074 mean: 5.987 median: 5.854 HAE: 3.701 low: 0.24 |
|
| Price To Earnings (P/E) | 54.985 | |
| Price To Earnings QoQ | 30.021 % | |
| Price To Earnings YoY | -14.708 % | |
| Price To Earnings IPRWA | high: 269.298 mean: 119.972 median: 101.834 HAE: 54.985 low: -315.07 |
|
| PE/G Ratio | 17.456 | |
| Price To Sales (P/S) | 9.951 | |
| Price To Sales QoQ | 29.733 % | |
| Price To Sales YoY | -10.0 % | |
| Price To Sales IPRWA | high: 52.884 median: 23.476 mean: 20.25 HAE: 9.951 low: -13.339 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 53.918 | |
| Forward PE/G | 17.117 | |
| Forward P/S | 28.584 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 4.277 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.137 | |
| Asset Turnover Ratio QoQ | 2.959 % | |
| Asset Turnover Ratio YoY | -0.312 % | |
| Asset Turnover Ratio IPRWA | high: 0.512 HAE: 0.137 median: 0.133 mean: 0.127 low: -0.209 |
|
| Receivables Turnover | 1.683 | |
| Receivables Turnover Ratio QoQ | 4.857 % | |
| Receivables Turnover Ratio YoY | 2.736 % | |
| Receivables Turnover Ratio IPRWA | high: 2.907 mean: 1.882 median: 1.867 HAE: 1.683 low: 0.47 |
|
| Inventory Turnover | 0.416 | |
| Inventory Turnover Ratio QoQ | 9.189 % | |
| Inventory Turnover Ratio YoY | -0.577 % | |
| Inventory Turnover Ratio IPRWA | high: 2.05 mean: 0.672 median: 0.548 HAE: 0.416 low: 0.16 |
|
| Days Sales Outstanding (DSO) | 54.213 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 242.468 | |
| Cash Conversion Cycle Days QoQ | -8.48 % | |
| Cash Conversion Cycle Days YoY | 4.687 % | |
| Cash Conversion Cycle Days IPRWA | high: 453.393 HAE: 242.468 mean: 171.385 median: 165.533 low: -118.454 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.839 | |
| CapEx To Revenue | -0.019 | |
| CapEx To Depreciation | -0.386 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 1.8 B | |
| Net Invested Capital | $ 2.1 B | |
| Invested Capital | $ 2.1 B | |
| Net Tangible Assets | $ -115.11 M | |
| Net Working Capital | $ 403.8 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.673 | |
| Current Ratio | 1.748 | |
| Current Ratio QoQ | 6.532 % | |
| Current Ratio YoY | -55.994 % | |
| Current Ratio IPRWA | high: 20.133 mean: 2.713 median: 1.893 HAE: 1.748 low: 0.168 |
|
| Quick Ratio | 1.153 | |
| Quick Ratio QoQ | 12.203 % | |
| Quick Ratio YoY | -54.818 % | |
| Quick Ratio IPRWA | high: 12.347 mean: 2.038 median: 1.469 HAE: 1.153 low: 0.366 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 12.922 | |
| Cost Of Debt | 0.452 % | |
| Interest Coverage Ratio | 9.082 | |
| Interest Coverage Ratio QoQ | 11.886 % | |
| Interest Coverage Ratio YoY | 40.191 % | |
| Interest Coverage Ratio IPRWA | high: 60.521 median: 25.964 mean: 20.973 HAE: 9.082 low: -107.569 |
|
| Operating Cash Flow Ratio | 0.158 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 37.99 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 1.996 % | |
| Revenue Growth | 3.56 % | |
| Revenue Growth QoQ | 93.268 % | |
| Revenue Growth YoY | 305.929 % | |
| Revenue Growth IPRWA | high: 54.001 % median: 12.969 % mean: 10.214 % HAE: 3.56 % low: -28.254 % |
|
| Earnings Growth | 3.15 % | |
| Earnings Growth QoQ | -79.618 % | |
| Earnings Growth YoY | -49.6 % | |
| Earnings Growth IPRWA | high: 188.889 % mean: 10.279 % median: 6.667 % HAE: 3.15 % low: -142.105 % |
|
| MARGINS | ||
| Gross Margin | 59.707 % | |
| Gross Margin QoQ | 0.353 % | |
| Gross Margin YoY | 7.522 % | |
| Gross Margin IPRWA | high: 96.557 % median: 64.538 % mean: 62.797 % HAE: 59.707 % low: -16.207 % |
|
| EBIT Margin | 19.883 % | |
| EBIT Margin QoQ | 11.265 % | |
| EBIT Margin YoY | 17.401 % | |
| EBIT Margin IPRWA | high: 33.51 % median: 20.883 % mean: 20.745 % HAE: 19.883 % low: -144.871 % |
|
| Return On Sales (ROS) | 20.094 % | |
| Return On Sales QoQ | -1.942 % | |
| Return On Sales YoY | 18.647 % | |
| Return On Sales IPRWA | high: 35.479 % mean: 22.004 % median: 21.965 % HAE: 20.094 % low: -169.778 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 87.2 M | |
| Free Cash Flow Yield | 2.586 % | |
| Free Cash Flow Yield QoQ | -38.923 % | |
| Free Cash Flow Yield YoY | 182.932 % | |
| Free Cash Flow Yield IPRWA | high: 4.073 % HAE: 2.586 % median: 0.969 % mean: 0.893 % low: -15.714 % |
|
| Free Cash Growth | -17.958 % | |
| Free Cash Growth QoQ | -102.644 % | |
| Free Cash Growth YoY | 69.639 % | |
| Free Cash Growth IPRWA | high: 265.331 % mean: 5.046 % median: -0.761 % HAE: -17.958 % low: -303.638 % |
|
| Free Cash To Net Income | 1.949 | |
| Cash Flow Margin | 25.226 % | |
| Cash Flow To Earnings | 1.911 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.814 % | |
| Return On Assets QoQ | 14.956 % | |
| Return On Assets YoY | 22.32 % | |
| Return On Assets IPRWA | high: 15.87 % mean: 2.025 % HAE: 1.814 % median: 1.556 % low: -29.663 % |
|
| Return On Capital Employed (ROCE) | 3.454 % | |
| Return On Equity (ROE) | 0.049 | |
| Return On Equity QoQ | 7.772 % | |
| Return On Equity YoY | 18.747 % | |
| Return On Equity IPRWA | high: 0.174 HAE: 0.049 mean: 0.03 median: 0.028 low: -0.518 |
|
| DuPont ROE | 5.082 % | |
| Return On Invested Capital (ROIC) | 2.354 % | |
| Return On Invested Capital QoQ | 10.672 % | |
| Return On Invested Capital YoY | -116.768 % | |
| Return On Invested Capital IPRWA | high: 6.199 % mean: 2.69 % HAE: 2.354 % median: 2.127 % low: -19.559 % |
|